Portfolio Holdings by Security (As of Deposit Date)

  • Ticker
    Security Description
    Deposit %
  • ACAD
    ACADIA Pharmaceuticals Inc.
    5.00
  • ACOR
    Acorda Therapeutics, Inc.
    2.68
  • ALXN
    Alexion Pharmaceuticals, Inc.
    3.27
  • ARIA
    ARIAD Pharmaceuticals, Inc.
    3.24
  • ATRA
    Atara Biotherapeutics, Inc.
    3.73
  • BLUE
    bluebird bio, Inc.
    3.12
  • BMRN
    BioMarin Pharmaceutical Inc.
    2.88
  • CEMP
    Cempra, Inc.
    3.29
  • CLDX
    Celldex Therapeutics, Inc.
    3.77
  • CLVS
    Clovis Oncology, Inc.
    2.18
  • CMRX
    Chimerix, Inc.
    3.41
  • HZNP
    Horizon Pharma plc
    2.39
  • ICPT
    Intercept Pharmaceuticals, Inc.
    3.77
  • IMGN
    ImmunoGen, Inc.
    3.43
  • INSM
    Insmed Incorporated
    3.31
  • IONS
    Ionis Pharmaceuticals, Inc.
    3.30
  • JAZZ
    Jazz Pharmaceuticals plc
    3.28
  • JUNO
    Juno Therapeutics, Inc.
    3.30
  • KITE
    Kite Pharma, Inc.
    2.78
  • LGND
    Ligand Pharmaceuticals Incorporated
    3.64
  • LXRX
    Lexicon Pharmaceuticals, Inc.
    3.73
  • MDCO
    The Medicines Company
    3.06
  • NBIX
    Neurocrine Biosciences, Inc.
    3.89
  • NKTR
    Nektar Therapeutics
    3.61
  • PRTA
    Prothena Corporation plc
    4.05
  • PTLA
    Portola Pharmaceuticals, Inc.
    2.43
  • RARE
    Ultragenyx Pharmaceutical Inc.
    3.67
  • SGEN
    Seattle Genetics, Inc.
    3.45
  • VRTX
    Vertex Pharmaceuticals Incorporated
    2.83
  • XLRN
    Acceleron Pharma Inc.
    3.51

Health Care

  • Ticker
    Security Description
    Deposit %
  • ACAD
    ACADIA Pharmaceuticals Inc.
    5.00
  • XLRN
    Acceleron Pharma Inc.
    3.51
  • ACOR
    Acorda Therapeutics, Inc.
    2.68
  • ALXN
    Alexion Pharmaceuticals, Inc.
    3.27
  • ARIA
    ARIAD Pharmaceuticals, Inc.
    3.24
  • ATRA
    Atara Biotherapeutics, Inc.
    3.73
  • BMRN
    BioMarin Pharmaceutical Inc.
    2.88
  • BLUE
    bluebird bio, Inc.
    3.12
  • CLDX
    Celldex Therapeutics, Inc.
    3.77
  • CEMP
    Cempra, Inc.
    3.29
  • CMRX
    Chimerix, Inc.
    3.41
  • CLVS
    Clovis Oncology, Inc.
    2.18
  • HZNP
    Horizon Pharma plc
    2.39
  • IMGN
    ImmunoGen, Inc.
    3.43
  • INSM
    Insmed Incorporated
    3.31
  • ICPT
    Intercept Pharmaceuticals, Inc.
    3.77
  • IONS
    Ionis Pharmaceuticals, Inc.
    3.30
  • JAZZ
    Jazz Pharmaceuticals plc
    3.28
  • JUNO
    Juno Therapeutics, Inc.
    3.30
  • KITE
    Kite Pharma, Inc.
    2.78
  • LXRX
    Lexicon Pharmaceuticals, Inc.
    3.73
  • LGND
    Ligand Pharmaceuticals Incorporated
    3.64
  • MDCO
    The Medicines Company
    3.06
  • NKTR
    Nektar Therapeutics
    3.61
  • NBIX
    Neurocrine Biosciences, Inc.
    3.89
  • PTLA
    Portola Pharmaceuticals, Inc.
    2.43
  • PRTA
    Prothena Corporation plc
    4.05
  • SGEN
    Seattle Genetics, Inc.
    3.45
  • RARE
    Ultragenyx Pharmaceutical Inc.
    3.67
  • VRTX
    Vertex Pharmaceuticals Incorporated
    2.83

Summary

Description
  • Trust Name

    Healthcare Innovations, 1

  • Trust Symbol

    SMHCAX

Deposit Data
  • Deposit Date

    05-03-2016

  • Termination Date

    05-03-2018

  • Minimum Investment

    100

  • Distribution Frequency

    Monthly (if any)

  • Initial Public Offer Price

    $10.00

  • Est. Net Annual Income*

    0.00

CUSIP
  • Cash Cusip

    83183W104

  • Reinvest Cusip

    83183W112

  • Fee Cash Cusip

    83183W120

  • Fee Invest Cusip

    83183W138

*Estimated Net Annual First Year Distribution per unit is computed by dividing the estimated annual income of the underlying securities less the expense per unit by the number of units outstanding. The estimated net annual distributions for subsequent years are expected to be less than estimated distributions for the first year because a portion of the securities included in the trust portfolio will be sold during the first year to pay for organization costs, the creation and development fee and the deferred sales charge. The actual net annual distributions will vary with changes in the trust’s fees and expenses and income of the underlying securities.